Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease: Analysis of [11C] raclopride PET study
Identifieur interne : 002567 ( Main/Exploration ); précédent : 002566; suivant : 002568Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease: Analysis of [11C] raclopride PET study
Auteurs : Ji Youn Kim [Corée du Sud] ; Eun Joo Chung [Corée du Sud] ; Won Yong Lee [Corée du Sud] ; Hee Young Shin [Corée du Sud] ; Gyeong Han Lee [Corée du Sud] ; Yearn-Seong Choe [Corée du Sud] ; Yong Choi [Corée du Sud] ; Byeong Joon Kim [Corée du Sud]Source :
- Movement Disorders [ 0885-3185 ] ; 2008-01-30.
English descriptors
- KwdEn :
- Adult, Aged, Electric Stimulation (methods), Female, Humans, Male, Middle Aged, Parkinson Disease (radionuclide imaging), Parkinson Disease (therapy), Parkinson's disease, Positron-Emission Tomography, Raclopride (metabolism), Severity of Illness Index, Transcranial Magnetic Stimulation (methods), Tritium (diagnostic use), [11C] raclopride PET, placebo effect, repetitive transcranial magnetic stimulation.
- MESH :
- chemical , diagnostic use : Tritium.
- chemical , metabolism : Raclopride.
- methods : Electric Stimulation, Transcranial Magnetic Stimulation.
- radionuclide imaging : Parkinson Disease.
- therapy : Parkinson Disease.
- Adult, Aged, Female, Humans, Male, Middle Aged, Positron-Emission Tomography, Severity of Illness Index.
Abstract
Repetitive transcranial magnetic stimulation (rTMS) has been used as a potential therapeutic tool in Parkinson's disease (PD). However, the therapeutic value and/or the placebo effect of rTMS on PD remain to be elucidated. To investigate the therapeutic value and/or placebo effect of rTMS in PD, we compared the motor section of unified PD rating scale (UPDRS III) and the amount of extracellular dopamine concentration using [11C] raclopride PET before and after two sessions of rTMS in 9 PD patients. During a consecutive 2 days while off‐medication, two series of 15 trains of 5 Hz‐frequency rTMS (intensity, 90% of the resting motor threshold) were applied to the hand area of more severely symptomatic motor cortex (MC). After unilateral rTMS of MC, mean raclopride binding potentials (BPs) were reduced not only in putaminal and caudate areas on the stimulated side (−4.9% and −6.5%, respectively) (P > 0.05) but also in putaminal and caudate areas of nonstimulated hemispheres (−6.6%, P > 0.05 and −12.1%, P = 0.049, respectively). UPDRS III scores were significantly decreased (35.0 ± 14.1 to 32.0 ± 13.4, P = 0.049). A reduction of raclopride BP in nonstimulated ventral striatum by unilateral rTMS supports the placebo response during rTMS. © 2007 Movement Disorder Society
Url:
DOI: 10.1002/mds.21787
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002004
- to stream Istex, to step Curation: 002004
- to stream Istex, to step Checkpoint: 001123
- to stream PubMed, to step Corpus: 002448
- to stream PubMed, to step Curation: 002448
- to stream PubMed, to step Checkpoint: 002023
- to stream Ncbi, to step Merge: 001F11
- to stream Ncbi, to step Curation: 001F11
- to stream Ncbi, to step Checkpoint: 001F11
- to stream Main, to step Merge: 003145
- to stream Main, to step Curation: 002567
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease: Analysis of [11C] raclopride PET study</title><author><name sortKey="Kim, Ji Youn" sort="Kim, Ji Youn" uniqKey="Kim J" first="Ji Youn" last="Kim">Ji Youn Kim</name></author><author><name sortKey="Chung, Eun Joo" sort="Chung, Eun Joo" uniqKey="Chung E" first="Eun Joo" last="Chung">Eun Joo Chung</name></author><author><name sortKey="Lee, Won Yong" sort="Lee, Won Yong" uniqKey="Lee W" first="Won Yong" last="Lee">Won Yong Lee</name></author><author><name sortKey="Shin, Hee Young" sort="Shin, Hee Young" uniqKey="Shin H" first="Hee Young" last="Shin">Hee Young Shin</name></author><author><name sortKey="Lee, Gyeong Han" sort="Lee, Gyeong Han" uniqKey="Lee G" first="Gyeong Han" last="Lee">Gyeong Han Lee</name></author><author><name sortKey="Choe, Yearn Eong" sort="Choe, Yearn Eong" uniqKey="Choe Y" first="Yearn-Seong" last="Choe">Yearn-Seong Choe</name></author><author><name sortKey="Choi, Yong" sort="Choi, Yong" uniqKey="Choi Y" first="Yong" last="Choi">Yong Choi</name></author><author><name sortKey="Kim, Byeong Joon" sort="Kim, Byeong Joon" uniqKey="Kim B" first="Byeong Joon" last="Kim">Byeong Joon Kim</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:ED373619261BBD422DBC0FA91FA1B95AD917206B</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.21787</idno><idno type="url">https://api.istex.fr/document/ED373619261BBD422DBC0FA91FA1B95AD917206B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002004</idno><idno type="wicri:Area/Istex/Curation">002004</idno><idno type="wicri:Area/Istex/Checkpoint">001123</idno><idno type="wicri:doubleKey">0885-3185:2008:Kim J:therapeutic:effect:of</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:17999422</idno><idno type="wicri:Area/PubMed/Corpus">002448</idno><idno type="wicri:Area/PubMed/Curation">002448</idno><idno type="wicri:Area/PubMed/Checkpoint">002023</idno><idno type="wicri:Area/Ncbi/Merge">001F11</idno><idno type="wicri:Area/Ncbi/Curation">001F11</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F11</idno><idno type="wicri:Area/Main/Merge">003145</idno><idno type="wicri:Area/Main/Curation">002567</idno><idno type="wicri:Area/Main/Exploration">002567</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease: Analysis of [11C] raclopride PET study</title><author><name sortKey="Kim, Ji Youn" sort="Kim, Ji Youn" uniqKey="Kim J" first="Ji Youn" last="Kim">Ji Youn Kim</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Chung, Eun Joo" sort="Chung, Eun Joo" uniqKey="Chung E" first="Eun Joo" last="Chung">Eun Joo Chung</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Lee, Won Yong" sort="Lee, Won Yong" uniqKey="Lee W" first="Won Yong" last="Lee">Won Yong Lee</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Shin, Hee Young" sort="Shin, Hee Young" uniqKey="Shin H" first="Hee Young" last="Shin">Hee Young Shin</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Lee, Gyeong Han" sort="Lee, Gyeong Han" uniqKey="Lee G" first="Gyeong Han" last="Lee">Gyeong Han Lee</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Choe, Yearn Eong" sort="Choe, Yearn Eong" uniqKey="Choe Y" first="Yearn-Seong" last="Choe">Yearn-Seong Choe</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Choi, Yong" sort="Choi, Yong" uniqKey="Choi Y" first="Yong" last="Choi">Yong Choi</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Kim, Byeong Joon" sort="Kim, Byeong Joon" uniqKey="Kim B" first="Byeong Joon" last="Kim">Byeong Joon Kim</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-01-30">2008-01-30</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="207">207</biblScope><biblScope unit="page" to="211">211</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">ED373619261BBD422DBC0FA91FA1B95AD917206B</idno><idno type="DOI">10.1002/mds.21787</idno><idno type="ArticleID">MDS21787</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Electric Stimulation (methods)</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (radionuclide imaging)</term><term>Parkinson Disease (therapy)</term><term>Parkinson's disease</term><term>Positron-Emission Tomography</term><term>Raclopride (metabolism)</term><term>Severity of Illness Index</term><term>Transcranial Magnetic Stimulation (methods)</term><term>Tritium (diagnostic use)</term><term>[11C] raclopride PET</term><term>placebo effect</term><term>repetitive transcranial magnetic stimulation</term></keywords><keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Tritium</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Raclopride</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Electric Stimulation</term><term>Transcranial Magnetic Stimulation</term></keywords><keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Positron-Emission Tomography</term><term>Severity of Illness Index</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Repetitive transcranial magnetic stimulation (rTMS) has been used as a potential therapeutic tool in Parkinson's disease (PD). However, the therapeutic value and/or the placebo effect of rTMS on PD remain to be elucidated. To investigate the therapeutic value and/or placebo effect of rTMS in PD, we compared the motor section of unified PD rating scale (UPDRS III) and the amount of extracellular dopamine concentration using [11C] raclopride PET before and after two sessions of rTMS in 9 PD patients. During a consecutive 2 days while off‐medication, two series of 15 trains of 5 Hz‐frequency rTMS (intensity, 90% of the resting motor threshold) were applied to the hand area of more severely symptomatic motor cortex (MC). After unilateral rTMS of MC, mean raclopride binding potentials (BPs) were reduced not only in putaminal and caudate areas on the stimulated side (−4.9% and −6.5%, respectively) (P > 0.05) but also in putaminal and caudate areas of nonstimulated hemispheres (−6.6%, P > 0.05 and −12.1%, P = 0.049, respectively). UPDRS III scores were significantly decreased (35.0 ± 14.1 to 32.0 ± 13.4, P = 0.049). A reduction of raclopride BP in nonstimulated ventral striatum by unilateral rTMS supports the placebo response during rTMS. © 2007 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Corée du Sud</li></country><settlement><li>Séoul</li></settlement></list><tree><country name="Corée du Sud"><noRegion><name sortKey="Kim, Ji Youn" sort="Kim, Ji Youn" uniqKey="Kim J" first="Ji Youn" last="Kim">Ji Youn Kim</name></noRegion><name sortKey="Choe, Yearn Eong" sort="Choe, Yearn Eong" uniqKey="Choe Y" first="Yearn-Seong" last="Choe">Yearn-Seong Choe</name><name sortKey="Choi, Yong" sort="Choi, Yong" uniqKey="Choi Y" first="Yong" last="Choi">Yong Choi</name><name sortKey="Chung, Eun Joo" sort="Chung, Eun Joo" uniqKey="Chung E" first="Eun Joo" last="Chung">Eun Joo Chung</name><name sortKey="Kim, Byeong Joon" sort="Kim, Byeong Joon" uniqKey="Kim B" first="Byeong Joon" last="Kim">Byeong Joon Kim</name><name sortKey="Lee, Gyeong Han" sort="Lee, Gyeong Han" uniqKey="Lee G" first="Gyeong Han" last="Lee">Gyeong Han Lee</name><name sortKey="Lee, Won Yong" sort="Lee, Won Yong" uniqKey="Lee W" first="Won Yong" last="Lee">Won Yong Lee</name><name sortKey="Shin, Hee Young" sort="Shin, Hee Young" uniqKey="Shin H" first="Hee Young" last="Shin">Hee Young Shin</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002567 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002567 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:ED373619261BBD422DBC0FA91FA1B95AD917206B
|texte= Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease: Analysis of [11C] raclopride PET study
}}
| This area was generated with Dilib version V0.6.23. |  |